Annual Operating Profit
-$40.50 M
+$30.42 M+42.89%
December 31, 2023
Summary
- As of February 8, 2025, SEEL annual operating income is -$40.50 million, with the most recent change of +$30.42 million (+42.89%) on December 31, 2023.
- During the last 3 years, SEEL annual operating profit has fallen by -$21.74 million (-115.89%).
- SEEL annual operating profit is now -809.38% below its all-time high of $5.71 million, reached on December 31, 1998.
Performance
SEEL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$3.14 M
+$2.92 M+48.16%
June 30, 2024
Summary
- As of February 8, 2025, SEEL quarterly operating income is -$3.14 million, with the most recent change of +$2.92 million (+48.16%) on June 30, 2024.
- Over the past year, SEEL quarterly operating profit has increased by +$9.46 million (+75.09%).
- SEEL quarterly operating profit is now -201.63% below its all-time high of $3.09 million, reached on March 31, 2003.
Performance
SEEL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$29.81 M
+$7.81 M+20.77%
June 30, 2024
Summary
- As of February 8, 2025, SEEL TTM operating income is -$29.81 million, with the most recent change of +$7.81 million (+20.77%) on June 30, 2024.
- Over the past year, SEEL TTM operating profit has increased by +$20.94 million (+41.26%).
- SEEL TTM operating profit is now -2571.21% below its all-time high of -$1.12 million, reached on September 30, 2009.
Performance
SEEL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SEEL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.9% | +75.1% | +41.3% |
| 3 y3 years | -115.9% | +82.8% | +58.0% |
| 5 y5 years | -342.7% | +7.5% | -28.2% |
SEEL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.9% | at high | +88.5% | at high | +62.8% |
| 5 y | 5-year | -115.9% | +42.9% | at high | +88.5% | -58.9% | +62.8% |
| alltime | all time | -809.4% | +42.9% | -201.6% | +88.5% | -2571.2% | +62.8% |
Seelos Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$3.14 M(-48.2%) | -$29.81 M(-20.8%) |
| Mar 2024 | - | -$6.05 M(-24.4%) | -$37.62 M(-7.1%) |
| Dec 2023 | -$40.50 M(-42.9%) | -$8.01 M(-36.4%) | -$40.50 M(-20.2%) |
| Sep 2023 | - | -$12.60 M(+15.1%) | -$50.74 M(-8.7%) |
| Jun 2023 | - | -$10.95 M(+22.6%) | -$55.55 M(-15.6%) |
| Mar 2023 | - | -$8.93 M(-51.1%) | -$65.84 M(-7.2%) |
| Dec 2022 | -$70.92 M(+15.0%) | -$18.26 M(+4.9%) | -$70.92 M(-11.4%) |
| Sep 2022 | - | -$17.41 M(-18.0%) | -$80.03 M(+8.8%) |
| Jun 2022 | - | -$21.24 M(+51.6%) | -$73.53 M(+24.5%) |
| Mar 2022 | - | -$14.01 M(-48.8%) | -$59.07 M(-4.2%) |
| Dec 2021 | -$61.67 M(+228.7%) | -$27.37 M(+150.9%) | -$61.67 M(+53.6%) |
| Sep 2021 | - | -$10.91 M(+61.1%) | -$40.14 M(+20.5%) |
| Jun 2021 | - | -$6.77 M(-59.2%) | -$33.31 M(+11.6%) |
| Mar 2021 | - | -$16.61 M(+184.2%) | -$29.86 M(+59.2%) |
| Dec 2020 | -$18.76 M(-36.9%) | -$5.84 M(+43.1%) | -$18.76 M(-19.3%) |
| Sep 2020 | - | -$4.08 M(+23.0%) | -$23.24 M(+1.8%) |
| Jun 2020 | - | -$3.32 M(-39.7%) | -$22.84 M(-0.3%) |
| Mar 2020 | - | -$5.51 M(-46.7%) | -$22.91 M(-23.0%) |
| Dec 2019 | -$29.75 M(+225.2%) | -$10.33 M(+180.6%) | -$29.75 M(+12.6%) |
| Sep 2019 | - | -$3.68 M(+8.5%) | -$26.42 M(+10.9%) |
| Jun 2019 | - | -$3.39 M(-72.5%) | -$23.83 M(+5.1%) |
| Mar 2019 | - | -$12.34 M(+76.2%) | -$22.67 M(+78.8%) |
| Dec 2018 | -$9.15 M(-14.3%) | -$7.00 M(+544.3%) | -$12.68 M(+52.3%) |
| Sep 2018 | - | -$1.09 M(-51.4%) | -$8.32 M(-24.0%) |
| Jun 2018 | - | -$2.24 M(-4.9%) | -$10.95 M(-1.8%) |
| Mar 2018 | - | -$2.35 M(-11.2%) | -$11.16 M(+4.7%) |
| Dec 2017 | -$10.67 M(-21.9%) | -$2.65 M(-28.7%) | -$10.66 M(+1.4%) |
| Sep 2017 | - | -$3.72 M(+52.2%) | -$10.52 M(+23.4%) |
| Jun 2017 | - | -$2.44 M(+31.7%) | -$8.52 M(-20.4%) |
| Mar 2017 | - | -$1.85 M(-26.1%) | -$10.70 M(-21.7%) |
| Dec 2016 | -$13.66 M(-35.7%) | -$2.51 M(+45.7%) | -$13.68 M(-6.2%) |
| Sep 2016 | - | -$1.72 M(-62.8%) | -$14.58 M(-22.2%) |
| Jun 2016 | - | -$4.63 M(-4.2%) | -$18.75 M(-6.0%) |
| Mar 2016 | - | -$4.83 M(+41.5%) | -$19.95 M(-6.1%) |
| Dec 2015 | -$21.25 M(-12.8%) | -$3.41 M(-42.1%) | -$21.25 M(-39.1%) |
| Sep 2015 | - | -$5.89 M(+1.2%) | -$34.92 M(+8.4%) |
| Jun 2015 | - | -$5.82 M(-4.9%) | -$32.21 M(+23.9%) |
| Mar 2015 | - | -$6.12 M(-64.2%) | -$25.98 M(+6.6%) |
| Dec 2014 | -$24.36 M(+29.6%) | -$17.08 M(+436.7%) | -$24.36 M(+114.7%) |
| Sep 2014 | - | -$3.18 M(-897.5%) | -$11.35 M(-4.9%) |
| Jun 2014 | - | $399.00 K(-108.9%) | -$11.94 M(-30.3%) |
| Mar 2014 | - | -$4.50 M(+10.8%) | -$17.14 M(-8.8%) |
| Dec 2013 | -$18.80 M(+10.5%) | -$4.07 M(+7.8%) | -$18.80 M(-11.3%) |
| Sep 2013 | - | -$3.77 M(-21.4%) | -$21.20 M(+6.7%) |
| Jun 2013 | - | -$4.80 M(-22.1%) | -$19.88 M(+2.3%) |
| Mar 2013 | - | -$6.16 M(-4.7%) | -$19.42 M(+14.4%) |
| Dec 2012 | -$17.01 M(+9.5%) | -$6.46 M(+163.9%) | -$16.97 M(+35.2%) |
| Sep 2012 | - | -$2.45 M(-43.6%) | -$12.55 M(+1.8%) |
| Jun 2012 | - | -$4.35 M(+17.1%) | -$12.33 M(-22.0%) |
| Mar 2012 | - | -$3.71 M(+81.6%) | -$15.81 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$15.53 M(+38.2%) | -$2.04 M(-8.2%) | -$15.53 M(-9.6%) |
| Sep 2011 | - | -$2.23 M(-71.5%) | -$17.17 M(-1.8%) |
| Jun 2011 | - | -$7.83 M(+128.6%) | -$17.49 M(+41.8%) |
| Mar 2011 | - | -$3.42 M(-7.2%) | -$12.33 M(+10.5%) |
| Dec 2010 | -$11.23 M(+247.3%) | -$3.69 M(+44.7%) | -$11.16 M(+20.6%) |
| Sep 2010 | - | -$2.55 M(-4.5%) | -$9.26 M(+21.4%) |
| Jun 2010 | - | -$2.67 M(+18.2%) | -$7.63 M(+21.7%) |
| Mar 2010 | - | -$2.26 M(+26.5%) | -$6.27 M(+93.7%) |
| Dec 2009 | -$3.23 M(-37.5%) | -$1.78 M(+95.2%) | -$3.23 M(+189.8%) |
| Sep 2009 | - | -$914.40 K(-30.1%) | -$1.12 M(-64.0%) |
| Jun 2009 | - | -$1.31 M(-269.2%) | -$3.10 M(+7.6%) |
| Mar 2009 | - | $773.30 K(+131.7%) | -$2.88 M(-44.3%) |
| Dec 2008 | -$5.17 M(-44.9%) | $333.80 K(-111.5%) | -$5.17 M(-41.8%) |
| Sep 2008 | - | -$2.90 M(+165.7%) | -$8.89 M(+11.1%) |
| Jun 2008 | - | -$1.09 M(-28.3%) | -$8.00 M(-10.0%) |
| Mar 2008 | - | -$1.52 M(-55.0%) | -$8.88 M(-5.4%) |
| Dec 2007 | -$9.39 M(+2.8%) | -$3.38 M(+68.3%) | -$9.39 M(+8.4%) |
| Sep 2007 | - | -$2.01 M(+1.7%) | -$8.66 M(+0.5%) |
| Jun 2007 | - | -$1.98 M(-2.4%) | -$8.61 M(+4.2%) |
| Mar 2007 | - | -$2.02 M(-23.6%) | -$8.27 M(-9.4%) |
| Dec 2006 | -$9.13 M(-41.9%) | -$2.65 M(+34.7%) | -$9.13 M(-10.1%) |
| Sep 2006 | - | -$1.97 M(+20.7%) | -$10.16 M(-10.3%) |
| Jun 2006 | - | -$1.63 M(-43.6%) | -$11.32 M(-19.2%) |
| Mar 2006 | - | -$2.89 M(-21.5%) | -$14.02 M(-10.7%) |
| Dec 2005 | -$15.70 M(-9.3%) | -$3.68 M(+17.3%) | -$15.70 M(-6.3%) |
| Sep 2005 | - | -$3.13 M(-27.5%) | -$16.76 M(-8.2%) |
| Jun 2005 | - | -$4.33 M(-5.2%) | -$18.26 M(+1.6%) |
| Mar 2005 | - | -$4.56 M(-3.6%) | -$17.98 M(+3.9%) |
| Dec 2004 | -$17.30 M(+21.6%) | -$4.74 M(+2.3%) | -$17.30 M(-0.8%) |
| Sep 2004 | - | -$4.63 M(+14.5%) | -$17.45 M(+11.4%) |
| Jun 2004 | - | -$4.05 M(+4.0%) | -$15.66 M(+4.2%) |
| Mar 2004 | - | -$3.89 M(-20.3%) | -$15.03 M(+86.7%) |
| Dec 2003 | -$14.23 M(-48.4%) | -$4.88 M(+71.3%) | -$8.05 M(-29.6%) |
| Sep 2003 | - | -$2.85 M(-16.6%) | -$11.43 M(-25.4%) |
| Jun 2003 | - | -$3.41 M(-210.5%) | -$15.32 M(-18.6%) |
| Mar 2003 | - | $3.09 M(-137.4%) | -$18.83 M(-31.7%) |
| Dec 2002 | -$27.56 M(+60.2%) | -$8.26 M(+22.4%) | -$27.56 M(+8.6%) |
| Sep 2002 | - | -$6.74 M(-2.6%) | -$25.37 M(+13.7%) |
| Jun 2002 | - | -$6.92 M(+22.8%) | -$22.30 M(+16.2%) |
| Mar 2002 | - | -$5.64 M(-7.0%) | -$19.19 M(+11.6%) |
| Dec 2001 | -$17.20 M(+70.3%) | -$6.06 M(+64.8%) | -$17.20 M(+15.6%) |
| Sep 2001 | - | -$3.68 M(-3.5%) | -$14.88 M(+9.9%) |
| Jun 2001 | - | -$3.81 M(+4.5%) | -$13.54 M(+9.7%) |
| Mar 2001 | - | -$3.65 M(-2.4%) | -$12.34 M(+22.2%) |
| Dec 2000 | -$10.10 M(+148.9%) | -$3.74 M(+59.6%) | -$10.10 M(+58.7%) |
| Sep 2000 | - | -$2.34 M(-10.5%) | -$6.36 M(+58.2%) |
| Jun 2000 | - | -$2.62 M(+86.0%) | -$4.02 M(+186.0%) |
| Mar 2000 | - | -$1.41 M | -$1.41 M |
| Dec 1999 | -$4.06 M(-171.1%) | - | - |
| Dec 1998 | $5.71 M(-248.4%) | - | - |
| Dec 1997 | -$3.85 M | - | - |
FAQ
- What is Seelos Therapeutics annual operating income?
- What is the all time high annual operating profit for Seelos Therapeutics?
- What is Seelos Therapeutics annual operating profit year-on-year change?
- What is Seelos Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly operating profit year-on-year change?
- What is Seelos Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Seelos Therapeutics?
- What is Seelos Therapeutics TTM operating profit year-on-year change?
What is Seelos Therapeutics annual operating income?
The current annual operating profit of SEEL is -$40.50 M
What is the all time high annual operating profit for Seelos Therapeutics?
Seelos Therapeutics all-time high annual operating income is $5.71 M
What is Seelos Therapeutics annual operating profit year-on-year change?
Over the past year, SEEL annual operating income has changed by +$30.42 M (+42.89%)
What is Seelos Therapeutics quarterly operating income?
The current quarterly operating profit of SEEL is -$3.14 M
What is the all time high quarterly operating profit for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly operating income is $3.09 M
What is Seelos Therapeutics quarterly operating profit year-on-year change?
Over the past year, SEEL quarterly operating income has changed by +$9.46 M (+75.09%)
What is Seelos Therapeutics TTM operating income?
The current TTM operating profit of SEEL is -$29.81 M
What is the all time high TTM operating profit for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM operating income is -$1.12 M
What is Seelos Therapeutics TTM operating profit year-on-year change?
Over the past year, SEEL TTM operating income has changed by +$20.94 M (+41.26%)